Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2008
10/16/2008US20080254536 Method of elevating photosynthesis speed of plant by improving pyruvate phosphate dikinase
10/16/2008US20080254524 Increased Ethanol Production from Xylose
10/16/2008US20080254522 Microbial host cells comprising isolated polynucleotides; converting eicosadienoic acid to gamma linolenic acid and/or eicosatrienoic acid to eicosatetraenoic acid in oleaginous yeast
10/16/2008US20080254519 Via dioxygenases; proteins; genes
10/16/2008US20080254516 Method of Isolating Nucleic Acid Targets
10/16/2008US20080254510 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
10/16/2008US20080254507 Multimeric human immunodeficiency viricidal agent
10/16/2008US20080254506 Claudin polypeptides
10/16/2008US20080254470 Using CpG methylation patterning of paired-like homeodomain transcription factor 2 (PITX2 ) as evaluative tool in diagnosing tumor disorders
10/16/2008US20080254466 Heregulin-like Factor
10/16/2008US20080254461 METHODS FOR ISOLATING AND CHARACTERIZING ENDOGENOUS mRNA-PROTEIN (mRNP) COMPLEXES
10/16/2008US20080254456 Using tumor marker antigen expression as evaluative tool in diagnosing hepatic cancer
10/16/2008US20080254449 Nucleotide sequences for use as probes in detection of shiga toxin bacteria
10/16/2008US20080254447 Using CpG site methylation of breast cancer tumor antigens as evaluative tools in prognosing/diagnosing cell proliferative disorders
10/16/2008US20080254195 Isolated nucleic acid fragments and recombinant constructs; plant cells, transgenic seeds, progeny plants
10/16/2008US20080254070 Bacterial secreted protein for use in generating vaccine for prevention of streptococcal infection; immunotherapy
10/16/2008US20080254048 He4 monoclonal antibodies and methods for their use
10/16/2008US20080254031 Nucleotide sequences coding tumor antigens for use as diagnostic tool in detection and staging of cell proliferative disorders
10/16/2008US20080254027 Optimized CD5 antibodies and methods of using the same
10/16/2008US20080254026 Tumor necrosis factor specific immunoglobulin for use in classification, treatment and prevention of autoimmune, liver, arthritic, skin and cell proliferative disorders
10/16/2008US20080254024 Anti-ephb2 antibodies and methods using same
10/16/2008US20080254021 Tie1-binding ligands
10/16/2008US20080254020 Protein fusions comprising immunoglobulin regions exhibiting improved bioefficacy in multidose administration for use in treatment of infection, cell proliferative, autoimmune and inflammatory disorders
10/16/2008US20080254007 Human Mesenchymal Progenitor Cell
10/16/2008US20080253989 Neuron Regeneration
10/16/2008US20080253977 Nucleic acid encoding plant lipase polypeptide isolated from Deschampsia antarctica; host cell from Pichia containing expression vector; genetic engineering; waste water cleaning; sunscreen agents
10/16/2008US20080253966 Diagnostic, Prognostic, and Therapeutic Factor Smac/Diablo in Human Cancer
10/16/2008DE102006035392A1 Prognostische Marker für die Vorhersage des fünfjährigen progressionsfreien Überlebens von Patienten mit Kolonkarzinomen basierend auf Expressionsprofilen von biologischen Proben Prognostic markers for the prediction of the five-year progression-free survival of patients with colon cancer based on expression profiles of biological samples
10/16/2008CA2683602A1 Selection method for cell internalizing nucleic acids
10/16/2008CA2676415A1 Genemap of the human genes associated with endometriosis
10/15/2008EP1980568A1 Ethinylated hetero dinucleotide phosphate analoga, method for their manufacture and application thereof
10/15/2008EP1979490A2 MITIGATION OF Cot-1 DNA DISTORTION IN NUCLEIC ACID HYBRIDIZATION
10/15/2008EP1979488A2 Immunostimulatory combinations of tnfrsf, tlr, nlr, rhr, purinergic receptor, and cytokine receptor agoinsts for vaccines and tumor immunotherapy
10/15/2008EP1979364A2 Rna containing modified nucleosides and methods of use thereof
10/15/2008EP1979088A2 Use of acid scavengers for the synthesis of standard length and long-mer nucleic acid arrays
10/15/2008EP1978999A2 Isolated mcpip and methods of use
10/15/2008EP1838868A4 Internal positive control for probe-based nucleic acid molecule assays and methods of making and using thereof
10/15/2008EP1692161A4 Chimeric chemokine receptor polypeptides
10/15/2008EP1576188B1 Methods for using riboprimers for strand displacement replication of target sequences
10/15/2008EP1259643B1 Nucleic acid detection methods using universal priming
10/15/2008EP1233980B1 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence
10/15/2008CN101287841A Anti-alpha(v)beta(6) antibodies and uses thereof
10/15/2008CN101287827A Amidases, nucleic acids encoding them and methods for making and using them
10/15/2008CN101287743A Integrated configuration system for use in a process plant
10/15/2008CN101287742A Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
10/15/2008CN101287536A Polyelectrolyte-coated ion-exchange particles
10/15/2008CN101285068A Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene
10/15/2008CN101284829A Conjugates of ascorbic acid and polyamide and method for preparing same
10/14/2008US7435874 Expresion vector comprising nucleotide sequences coding resistance protein (R1) for use as tool in generating transgenic tomato with fungal resistance; disease resistant plants; biological pest control
10/14/2008US7435811 Method for preferentially removing protein over nucleic acids using physical as well as chemical means of removal of the protein
10/14/2008US7435810 Immobilization of nucleotide in microarray; dissolving in print head ink jet solvent
10/14/2008US7435808 Expression vector comprising nucleotide sequences coding adipokine binding protein for use in treatment and prevention of diabetes, obesity, inflammation, cardiovascular and metabolic disorders
10/14/2008US7435807 Amplicon for use as reporter tool in transgenic, insect resistant, corn
10/14/2008US7435806 Detection of preferential transcription factor; obtain library, screen with probe, detect hybridization, recover clone, monitor transcriptional activity of protein codes in cloned nucleotide sequences
10/14/2008US7435804 Solubilizing inclusion bodies in a detergent to release the ScFv antibody; oxidizing to form disulfide bonds; removing the detergent;precipitating the oxidized ScFv antibodies; dissolving the precipitated ScFv antibodies in a denaturing solution; immobilizing on solid support; renaturing, elution
10/14/2008US7435803 Genetic engineered, chimera and human monoclonal antibodies that bind to lymphocytes CD antigens, used for diagnosis and prohylaxis of cancer and autoimmune diseases
10/14/2008US7435802 Bind to alpha-4 integrin; asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, acute leukocyte mediated lung injury
10/14/2008US7435798 Antibodies to a polypeptide encoded by a nucleic acid overexpressed in normal stomach, normal skin and kidney tumor
10/14/2008US7435793 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of non-insulin dependent diadetes mellitus, tumous, infection, skin disorders and inflammatory bowel disease
10/14/2008US7435792 Hybrid proteins that migrate retrogradely and transynaptically into the CNS
10/14/2008US7435723 In situ administering into vascular system by injection; gene therapy; controlling gene expression
10/14/2008US7435589 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
10/14/2008US7435583 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells
10/14/2008US7435574 Whole cell catalyst which expresses lactobacillus oxidase for use in generating/producing chrial enantiomer-enriched organic compounds
10/14/2008US7435571 DNA comprising a nucleotide sequence that encodes decaprenyl diphosphate (DPP) synthase
10/14/2008US7435570 Thermostable peroxide-driven cytochrome P450 oxygenase variants and methods of use
10/14/2008US7435562 Generating terminally modified oligonucleotide products via polymerases chain reaction and terminator primer residues for use in preparing specialty plasmids or expression vectors
10/14/2008US7435556 For increasing the ratio of the pHBA ester glucoside to total pHBA glucose conjugates in pHBA-producing microorganisms and green plant cells using nucleic acid fragments encoding plant glucosyltransferases that exhibit catalytic activity with p-hydroxybenzoic acid (pHBA) as a substrate
10/14/2008US7435550 Methods of using cytokine receptor zalpha11 to detect its ligands
10/14/2008US7435543 Screening and propagation of swine genomes with heat resistance phenotypes; analyzing nucleotide polymorphism in gene to calibrate fat thickness
10/14/2008US7435541 Restriction enzyme genotyping
10/14/2008US7435539 Typing of human enteroviruses
10/14/2008US7435410 Methods of treatment with interferson and albumin fusion protein
10/14/2008CA2273204C Fen-1 endonucleases, mixtures and cleavage methods
10/14/2008CA2190394C Recombinant viruses, preparation and use thereof in gene therapy
10/09/2008WO2008121867A1 Mrna interferase from myxococcus xanthus
10/09/2008WO2008121727A1 Identification of the causative mutation for hereditary equine regional dermal asthenia and a method for testing same
10/09/2008WO2008121604A2 Compositions and methods for inhibiting expression of a gene from the ebola
10/09/2008WO2008121563A2 Modified fgf-21 polypeptides and their uses
10/09/2008WO2008121377A2 System and method for wikifying content for knowledge navigation and discovery
10/09/2008WO2008121349A1 Tag and target delivery system
10/09/2008WO2008121009A1 Modified adiponectin proteins
10/09/2008WO2008121007A1 Novel saratan polypeptides and polynucleotides and methods of use thereof
10/09/2008WO2008120016A1 Modified nucleic acids
10/09/2008WO2008119191A1 Microfluidic methods for the separation of supercoiled dna
10/09/2008WO2008119190A1 Microfluidic platforms for genotyping
10/09/2008WO2008119181A1 Stabilized gold nanoparticles and methods of making the same
10/09/2008WO2008101024A3 Labeling and detection of nucleic acids
10/09/2008WO2008097277A3 Tcl1 expression in chronic lymphocytic leukemia (cll) regulated by mir-29 and mir-181
10/09/2008WO2008085551A3 Smallpox monoclonal antibody
10/09/2008WO2008073498A3 Artemisinic epoxide and methods for producing same
10/09/2008WO2008054612A3 Dna composition for eliciting an immune response against tumor-associated macrophages
10/09/2008WO2008042235A3 Thermotoga neapolitana dsm 5068 alkaline phosphatase (phoa) gene and recombinant enzyme production
10/09/2008WO2008039769A3 Methods and devices for analyzing small rna molecules
10/09/2008WO2008036680A3 Reagent sets and gene signatures for non-genotoxic hepatocarcinogenicity
10/09/2008WO2008024129A3 Synthetic genomes
10/09/2008WO2008022332A3 System, method and kit for replicating a dna array
10/09/2008WO2008022019A3 Promiscuous her-2/neu cd4 t cell epitopes
10/09/2008WO2008021457A3 Nested binary code symbol
10/09/2008WO2008019131A3 Methods and compositions for treating ige-mediated diseases
1 ... 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 ... 899